Our 7 review criteria
Every provider in our ranked directory is scored against these criteria. Weights reflect what matters most for patient safety and value.
Review methodology
How we review online GLP-1 providers
The exact 7-criteria framework GLP1Zoom uses to assess every GLP-1 telehealth provider — transparent, identical for all, and independent of affiliate commission.
Methodology reviewed May 27, 2026
Summary
GLP1Zoom reviews online GLP-1 providers against 7 weighted criteria: (1) regulatory status, (2) price transparency, (3) drug-menu breadth, (4) prescriber licensing, (5) third-party reviews, (6) state coverage, (7) shipping reliability. GLP1Zoom is affiliate-supported, sells no medications, and scores every provider identically.
1
Regulatory status
High weightFDA-approved brand medications score highest; compounded (503A/503B) medications are flagged with explicit caveats — same active ingredient, lower finished-product oversight.
2
Price transparency
High weightProviders publishing upfront monthly pricing score above those requiring a consultation to reveal cost. Hidden-fee patterns lower the score.
3
Drug-menu breadth
Medium weightRange of GLP-1 options offered (semaglutide, tirzepatide, liraglutide; injection + oral; brand + compounded).
4
Prescriber licensing
High weightVerification that the provider connects patients to US-licensed clinicians with synchronous or asynchronous consultation as state law requires.
5
Third-party reviews
Medium weightAggregate Trustpilot, BBB, and Reddit sentiment — weighted by review volume and recency.
6
State coverage
Medium weightNumber of US states the provider is licensed to ship to. Broader coverage scores higher.
7
Shipping & cold-chain
Low weightDelivery speed and cold-chain reliability for temperature-sensitive injectable GLP-1s.
Affiliate independence
GLP1Zoom earns a commission when readers sign up with a partner via our links. We are transparent about this — see our affiliate disclosure. Commission does NOT influence rankings: every provider is scored by the same 7 criteria, and we publish honest caveats (especially the FDA-approval gap for compounded medications). GLP1Zoom sells no medications and provides no clinical care — we are an independent comparison layer.
How often we update
Pricing re-verified monthly. Regulatory status tracked against FDA shortage-list changes. Full provider reviews refreshed quarterly or on material change. Every page shows its last-reviewed date.
Frequently asked questions
How does GLP1Zoom review online GLP-1 providers?
GLP1Zoom reviews each GLP-1 telehealth provider against 7 weighted criteria: regulatory status (FDA-brand vs compounded), price transparency, drug-menu breadth, prescriber licensing, third-party reviews (Trustpilot/BBB/Reddit), state coverage, and shipping/cold-chain reliability. We assess every provider identically and redirect to partners — GLP1Zoom sells no medications and holds no clinical liability.
Is GLP1Zoom independent or paid by providers?
GLP1Zoom earns affiliate commissions when readers sign up via partner links. This does not change rankings — every provider is scored by the same 7 criteria regardless of commission. We run no pharma display ads, sponsored placements, or paid review slots.
How often does GLP1Zoom update provider reviews?
Pricing is re-verified monthly against each provider website. Regulatory status is checked against FDA shortage-list updates. Full provider reviews are refreshed quarterly or when a material change occurs (new drug, pricing change, FDA action).
See the methodology in action: ranked provider directory · full scoring methodology · editorial policy.